Ethical concerns caused by integrative patient empowerment solutions for personalized medicine

Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS

Volumn , Issue , 2013, Pages 4775-4778

  Kuchinke, W ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DATA WAREHOUSES; DECISION SUPPORT SYSTEMS; INFORMATION MANAGEMENT; PHILOSOPHICAL ASPECTS; TOOLS; USER INTERFACES;

CLINICAL RESEARCH; CONTROL MECHANISM; DECISION SUPPORT TOOLS; INTELLIGENT DISPLAYS; PATIENT EMPOWERMENTS; PERSONALIZED MEDICINES; REQUIREMENTS ANALYSIS; TARGETED TREATMENT;

DIAGNOSIS;

EID: 84886507772     PISSN: 1557170X     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/EMBC.2013.6610615     Document Type: Conference Paper

References (18)

1. L. Hood and S. H. Friend, Predictive, personalized, preventive, participatory (P4) cancer medicine. Nature Rev Clin Oncology, 8, pp. 184, 2011.
2. I. Lejbkowicz, O. Caspi, and A. Miller "Participatory medicine and patient empowerment towards personalized healthcare in multiple sclerosis". Expert Review of Neurotherapeutics, Vol. 12, Number 3, pp. 343, 2012.
3. www.p-medicine.eu.
4. S. Rossi S, M-L. Christ-Neumann, S. Rueping, et al, "p-medicine: From data sharing and integration via VPH models to personalized medicine". e-cancer medical science, vol. 5, pp. 218, 2011.
5. S. Rossi (Ed.): Deliverable 15.1: Evaluation criteria and verification procedures of the p-medicine platform, p-medicine 2012.
6. Association for Clinical Data Management: PSI-Guide - Computer Systems Validation in Clinical Research. Version 1.1 (1998).
7. European Medicines Agency: ICH Topic E 6 (R1), Guideline for Good Clinical Practice, CPMP/ICH/135/95, London, UK, 2002.
8. P. R. Wolpe, "Personalized Medicine and Its Ethical Challenges", World Medical & Health Policy, Vol. 1: Issue 1, Article 5 (2009).
9. I. McDowell, Basic Ethical Principles, University of Ottawa (2012). Online available: http://www.med.uottawa.ca/sim/data/Ethics-e.htm (accessed: Oct. 2012).
10. National Bioethics Advisory Commission: Ethical and Policy in Research involving Human Participants. Georgetown University, 2001.
11. C. Weijer, J.M: Grimshaw, M.Taljaard, A. Binik et al., "Ethical issues posed by cluster randomized trials in health research", Trials, 12, pp. 100, 2011.
12. E. T. Juengst, M. A. Flatt, and R. A. Settersten, "Personalized Genomic Medicine and the Rhetoric of Empowerment". The Hastings Center Report. http://www.medscape.com/viewarticle/771362.
13. L. Clivio, A. Tinazzi, and E. Santoro, "The Contribution of information Technology: Towards a Better Clinical Data Management", DDR, vol. 67, pp. 246, 2006.
14. N. Forgo (Ed.). Deliverable No. 5.1: Setting up of the data protection and data security framework. p-medicine (31/01/2012).
15. European Science Foundation: Personalised Medicine for the European Citizen. Strasbourg, France: ESF, 2012.
16. I. Aujoulat, B. Young, and P. Salmon, "The psychological processes involved in patient empowerment", Orphanet Journal of Rare Diseases 2012, 7 (Suppl 2), A31.
17. J. Correia de Sousa, "How to measure patient empowerment". 2007.
18. European Commission 2010, European Textbook on Ethics in Research, pp. 51 (2010), online available:http://www.eurosfaire.prd.fr/7pc/doc/1292233423- textbook-on-ethics-report-en.pdf accessed July 2012.